-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Product Insights
NewNet Present Value Model: Cullinan Oncology Inc’s CLN-049
Empower your strategies with our Net Present Value Model: Cullinan Oncology Inc's CLN-049 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Endometriosis Clinical Trial Report Overview A total of 812 Endometriosis clinical trials were conducted as of February 2024. The Endometriosis clinical trial report provides a comprehensive understanding of the Endometriosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       Europe ·       Asia-Pacific ·       ...
-
Product Insights
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Ewing Sarcoma Clinical Trial Report Overview A total of 434 Ewing Sarcoma clinical trials were conducted as of February 2024. The Ewing Sarcoma clinical trial report provides a comprehensive understanding of the Ewing Sarcoma clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       ...
-
Thematic Analysis
NewRobotics in Agriculture – Thematic Intelligence
Robotics in Agriculture Thematic Report Overview Robotics will address challenges such as climate change and labor availability aiding the transformation in the future of agriculture. Robots will also support human workers by automating repetitive and strenuous tasks. Robots can also monitor crop health to optimize the application of agricultural inputs and assess readiness for harvesting, reducing food waste, and costs in the process. The Robotics in Agriculture thematic intelligence report gives you an in-depth insight into the robotics market and...
-
Product Insights
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
A total of 721 Hemophilia A (Factor VIII Deficiency) clinical trials were conducted as of February 2024. The Hemophilia A clinical trial report provides a comprehensive understanding of the Hemophilia A (Factor VIII Deficiency) clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       Europe...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BAY-2701250 in Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAY-2701250 in Pulmonary Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAY-2701250 in Pulmonary Hypertension Drug Details: BAY-2701250 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elinzanetant in Sleep Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elinzanetant in Sleep Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elinzanetant in Sleep Disorders Drug Details: Elinzanetant is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Asundexian in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Asundexian in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Asundexian in Acute Ischemic Stroke Drug Details: Asundexian is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BAY-1830839 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAY-1830839 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAY-1830839 in Rheumatoid Arthritis Drug Details: BAY-1830839 is under development for the...